[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]

[e-farmacos] WHO Drug Information Vol 21, No. 4, 2007


  • From: "Canas, Martin" <macanas@netverk.com.ar>
  • Date: Mon, 17 Dec 2007 16:42:19 -0600

Estimadas y estimados,

Esta disponible el WHO Drug Information Vol 21, No. 4, 2007, cuyo indice es:

Access to Essential Medicines

WHO celebrates thirty years of essential medicines 267

Pharmacovigilance Focus

Estrogen therapy and symptoms of parkinsonism: a review using WHO's ADR data base 270

Safety and Efficacy Issues

Perflutren injectable: serious cardiopulmonary reactions 281

Gefitinib: failure of overall survival vs docetaxel 281

Rituximab and progressive multifocal leukoencephalopathy 282

Implanon®: interactions and contraceptive failure 283

Atypical antipsychotic agents and extrapyramidal effects 283

Thiazolidinediones and reduced bone density 284

Renal impairment with zoledronic acid 285

Epoetins: unexplained excess mortality 285

Contraindicated use of sibutramine and cardiovascular reactions 287

Gadolinium-containing contrast agents: nephrogenic systemic fibrosis 287

Swedish Adjustable Gastric Band: incidents leading to explantation 288

Regulatory Action and News

Influenza virus vaccines: Southern hemisphere 2008 290

Withdrawal of cough medicines containing clobutinol? 290

Rimonabant warning: psychiatric conditions 290

Lumiracoxib registration cancelled 291

Lumiracoxib: withdrawal of higher doses 291

Ixabepilone approved for advanced breast cancer 292

Second-generation smallpox vaccine approved 292

Regulatory updates 293

Generic Medicines

Generic substitution in Jamaica: challenges to improving effectiveness 294

Frequently asked questions about generic medicines 300

Quality Assurance Update

Latest developments in ICH quality 304

Consultation Documents

International Pharmacopoeia

Oxytocin 309

Oxytocin injection 313

Recent Publications, Information and Events

GMP for herbal medicines 315

Quality of antiretrovirals in African countries 315

The Health Journey 315

Human rights guidelines for pharmaceutical companies 316

ARV price report from WHO 316

Proposed International Nonproprietary Names: List 98 317

Disponible en:

http://www.who.int/entity/medicines/publications/druginformation/Vol_21-4.pdf


Saludos,

Martin

Martin Canas
GAPURMED
La Plata
(Argentina)
macanas@netverk.com.ar